跳至主要内容
临床试验/NCT06906250
NCT06906250招募中不适用

European Venous Registry

IRCCS San Raffaele10 个研究点 分布在 9 个国家目标入组 100 人开始时间: 2025年7月5日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
10
主要终点
Clinical Severity Scores

研究概览

简要总结

The European Venous Registry (EVeR) is an international repository of data on the treatments and outcomes of people with deep venous disease. The registry is designed to evaluate the outcomes of venous interventions over a ten-year period, with the ultimate goal to inform clinical decision making through the delivery of scientific evidence.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with an imaging-confirmed new diagnosis of acute or chronic lower limb deep venous disease involving the iliac and/or common femoral veins, with or without extension to the inferior vena cava, or patients with an imaging-confirmed new diagnosis involving the IVC only.
  • Consent to enter registry.

排除标准

  • Unable to consent to enter into registry.
  • Isolated upper limb DVT.
  • Central venous thrombosis (e.g. superior vena cava obstruction).
  • Isolated deep vein thrombosis below the common femoral vein.
  • Isolated superficial venous thrombosis.
  • Isolated superficial venous thrombophlebitis.
  • Isolated varicose veins.
  • Aged <18 years.

结局指标

主要结局

Clinical Severity Scores

时间窗: end of the procedure

Difference of Clinical efficacy will be evaluated using the Villalta score (range 0-33). The patient was diagnosed as having Post-thrombotic syndrome if the Villalta score was ≥5 or if a venous ulcer was present. A score of 5-9 signifies mild disease, 10-14 moderate disease, and ≥15 severe disease.

次要结局

  • Venous Insufficiency Epidemiological and Economic Study/Quality of Life (VEINES-QOL)(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Baccellieri Domenico

Prof., M.D

IRCCS San Raffaele

研究点 (10)

Loading locations...

相似试验